Innophos Holdings Inc. (IPHS) Shares Bought by Nationwide Fund Advisors
Nationwide Fund Advisors boosted its position in shares of Innophos Holdings Inc. (NASDAQ:IPHS) by 43.0% during the second quarter, Holdings Channel reports. The institutional investor owned 89,788 shares of the company’s stock after buying an additional 27,002 shares during the period. Nationwide Fund Advisors owned about 0.47% of Innophos Holdings worth $3,790,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in IPHS. TIAA CREF Investment Management LLC boosted its position in shares of Innophos Holdings by 29.8% in the first quarter. TIAA CREF Investment Management LLC now owns 161,622 shares of the company’s stock worth $4,996,000 after buying an additional 37,127 shares in the last quarter. Renaissance Technologies LLC boosted its position in shares of Innophos Holdings by 30.8% in the first quarter. Renaissance Technologies LLC now owns 901,200 shares of the company’s stock worth $27,856,000 after buying an additional 212,200 shares in the last quarter. Smith Asset Management Group LP purchased a new position in shares of Innophos Holdings during the second quarter worth $2,138,000. Jacobs Levy Equity Management Inc. purchased a new position in shares of Innophos Holdings during the first quarter worth $1,616,000. Finally, BlackRock Group LTD boosted its position in shares of Innophos Holdings by 7.1% in the first quarter. BlackRock Group LTD now owns 24,851 shares of the company’s stock worth $768,000 after buying an additional 1,648 shares in the last quarter. 93.31% of the stock is currently owned by institutional investors.
Shares of Innophos Holdings Inc. (NASDAQ:IPHS) traded up 1.10% during trading on Wednesday, reaching $38.59. The company’s stock had a trading volume of 9,269 shares. The stock has a market cap of $742.51 million, a price-to-earnings ratio of 29.59 and a beta of 0.81. The company has a 50 day moving average of $39.90 and a 200-day moving average of $38.75. Innophos Holdings Inc. has a 12-month low of $22.06 and a 12-month high of $44.42.
Innophos Holdings (NASDAQ:IPHS) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.06. The business earned $181.90 million during the quarter, compared to analysts’ expectations of $199.70 million. Innophos Holdings had a return on equity of 9.83% and a net margin of 3.47%. The business’s quarterly revenue was down 16.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.65 earnings per share. Analysts forecast that Innophos Holdings Inc. will post $2.44 EPS for the current year.
Separately, Zacks Investment Research cut Innophos Holdings from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 6th.
In related news, Director Robert J. Zatta purchased 1,000 shares of Innophos Holdings stock in a transaction on Friday, September 9th. The stock was acquired at an average price of $40.31 per share, for a total transaction of $40,310.00. Following the completion of the transaction, the director now directly owns 6,351 shares in the company, valued at approximately $256,008.81. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 2.00% of the stock is owned by company insiders.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Its segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and GTSP & Other.
Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings Inc. (NASDAQ:IPHS).
Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.